i-Tracker

  • Innovative CLIA technology
  • Quantitative determination of drug and antibody levels against a given drug
  • First results in less than 35 minutes, 60 results/hour
  • Full compatibility with i-Track10 random access analyzer
  • Standardization to NIBSC/WHO Infliximab (#16/170) and Adalimumab (#17/236) international standards